vTv Therapeutics (VTVT) Income from Non-Controlling Interests (2015 - 2025)

vTv Therapeutics has disclosed Income from Non-Controlling Interests across 11 years of filings, most recently posting -$1.6 million for Q3 2025.

• In Q3 2025, Income from Non-Controlling Interests fell 55.82% year-over-year to -$1.6 million; the TTM figure through Jun 2026 stood at -$1.6 million (up 61.87% YoY), while the FY2025 annual figure was -$4.1 million, up 3.23% from the prior year.
• Income from Non-Controlling Interests came in at -$1.6 million for Q3 2025 at vTv Therapeutics, down from -$1.3 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of -$233000.0 in Q2 2021 to a low of -$2.4 million in Q4 2021.
• Average Income from Non-Controlling Interests over 5 years is -$1.3 million, with a median of -$1.2 million recorded in 2024.
• The largest YoY upside for Income from Non-Controlling Interests was 85.64% in 2021 against a maximum downside of 605.61% in 2021.
• Over 5 years, Income from Non-Controlling Interests stood at -$2.4 million in 2021, then soared by 44.7% to -$1.3 million in 2022, then grew by 28.4% to -$963000.0 in 2023, then increased by 16.61% to -$803000.0 in 2024, then sank by 105.11% to -$1.6 million in 2025.
• Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$1.6 million in Q3 2025, -$1.3 million in Q2 2025, and -$1.1 million in Q1 2025.